Our current newsletter features a great read by our Managing Partner Trevor Price on private equity and venture capital funding in the Healthcare world, and an article by Senior Associate Maura McGinn discussing the proven benefits of Women in the C-Suite with insight from Mary Tolan. Hope you enjoy!
Oxeon is pleased to announce Brian Garcia, previously of Healthagen, as Chief Technology Officer of Welltok. Welltok, the pioneer in health optimization, is revolutionizing the way population health managers align consumer actions and behaviors with the right incentives and rewards. Welltok is funded by New Enterprise Associates (NEA), IBM Watson and Qualcomm Ventures, as well as Emergence Capital Partners, InterWest Partners, Miramar Venture Partners and Okapi Venture Capital and recently completed a Series D funding round for $37M.
Oxeon is pleased to announce the placement of John Camperlengo and Karen Bartlett at Quartet Health. John is joining as General Counsel from Gentiva Health Services where he served as Chief Compliance Officer and General Counsel. Karen is joining Quartet to lead implementation and was previously a Senior Vice President at Value Options, Inc. Quartet Health is a technology company transforming behavioral healthcare. Quartet is an Oxeon portfolio investment and is additionally funded by Fidelity Biosciences, Polaris Partners, and Oak HC/FT.
Sutter Health is one of the nation’s leading community-based, not-for-profit health care networks of hospitals, physician organizations, home health and hospice agencies and other health care services. A new addition to our client portfolio, Sutter Health has hired Oxeon Partners to conduct Chief Marketing Officer and Chief Innovation Officer searches to join its leadership team.
Oxeon is pleased to announce the placement of Steve Whitehurst as Chief Executive Officer of Health Fidelity. Steve joins from Stericycle Communication Solutions, where he was Senior Vice President and GM. Health Fidelity is a healthcare big data analytics company that leverages an innovative proprietary natural language processing and inference platform to help organizations address risk and quality in value-based payment models. Health Fidelity has received funding from Charter Life Sciences as well as a grant from the United States National Science Foundation.
The Evolent Health executive team, led by their co-founders CEO Frank Williams, President Seth Blackley, and COO Tom Peterson, rang the opening bell at the New York Stock Exchange this morning in celebration. Evolent will be trading under the symbol EVH and raised $195.5 million in an oversubscribed IPO by offering 11.5 million shares at $17, above the range of $14 to $16. They originally planned to offer 10 million shares.